Maynard, MA, January 16, 2015 --(PR.com
)-- CHI Scientific, Inc., an innovator in the field of cell culture, today announced the release of PrimaCell™ protocols for culturing more than 300 types of primary cells that will enable scientists to overcome the variability of experimental results derived from today’s individualized time-consuming procedures. These bench-proven protocols developed for PrimaCell™ cell culture systems can be used by research scientists to grow cells directly from tissue or organs for research on biology and drug discovery.
The PrimaCell™ Kit-a standardized cell-culture system-is optimized to be cell-specific and tissue-specific for the selected species and tissue. "We have spent more than 8 years developing these protocols for each PrimaCell™ system and now more than 300 types of kits are available," says Alfred Chi, PhD, the company’s CEO, “We expect that PrimaCell™ will significantly impact both the primary cell research community and drug discovery industries."
The PrimaCell™ Kit includes all of the pre-made reagents required for tissue preparation, optimized tissue dissociation, isolation, and proliferation of the desired cells. This can greatly reduce working time from weeks to a few days. More importantly, each system includes a proprietary tissue dissociation system OptiTDS™, that produces a maximum number of single cells from selected tissue samples, a proprietary system, FibrOut™, that inhibits fibroblast or unwanted cell overgrowth over the desired cells, and a growth supplement and medium system that ensures optimized growth and proliferation of the desired cells.
About CHI Scientific, Inc. CHI Scientific, Inc. is an innovative biotechnology laboratory and company which is developing and marketing mid-range and high-end proprietary research products and tools that fundamentally accelerate basic research and drug discovery worldwide. CHI Scientific is a fast-growing life science company that is determined to bring cost effective and productive solutions to accelerate primary cell research.